Emily Lim
About Emily Lim
Emily Lim is an Associate Director at Instil Bio, where she has worked since 2020. She has extensive experience in process engineering and has held positions at A2 Biotherapeutics and Kite Pharma, focusing on Tumor Infiltrating Lymphocyte manufacturing processes and global process implementation.
Current Role at Instil Bio
Emily Lim serves as Associate Director at Instil Bio, a position she has held since 2020. In this role, she leads the implementation of process-related changes on a global scale. Emily facilitates cross-functional discussions with process development teams and manufacturing sites to ensure effective communication and execution of these changes. She oversees the technical aspects of process and product performance across multiple clinical manufacturing sites worldwide, contributing to the organization’s operational efficiency.
Previous Experience at A2 Biotherapeutics
Before joining Instil Bio, Emily Lim worked at A2 Biotherapeutics, Inc as a Senior Process Engineer from 2019 to 2020. During her tenure, she focused on enhancing manufacturing processes and contributed to the optimization of production techniques. Her experience at A2 Biotherapeutics provided her with valuable insights into biotherapeutic development and manufacturing.
Experience at Kite Pharma
Emily Lim has significant experience from her time at Kite Pharma, where she held multiple roles. She worked as a Process Engineer Associate from 2016 to 2018 and later as a Process Engineer III in Process Design and MSAT from 2018 to 2019. In these positions, she was involved in various aspects of process engineering, contributing to the development and implementation of manufacturing processes for cell therapies.
Education in Chemical Engineering
Emily Lim earned her Bachelor’s Degree in Chemical Engineering from the University of Southern California. Her academic background provided her with a strong foundation in engineering principles, which she has applied throughout her career in the biopharmaceutical industry.
Expertise in TIL Manufacturing Processes
Emily Lim leads knowledge transfers of Tumor Infiltrating Lymphocyte (TIL) manufacturing processes to new manufacturing sites in the US and UK. This role involves sharing expertise and ensuring that best practices are implemented at new locations, thereby enhancing the overall efficiency and effectiveness of TIL production.